KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axcelis Technologies (ACLS) Raw Materials (2016 - 2025)

Axcelis Technologies (ACLS) has disclosed Raw Materials for 15 consecutive years, with $259.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Raw Materials rose 14.04% year-over-year to $259.0 million, compared with a TTM value of $259.0 million through Dec 2025, up 14.04%, and an annual FY2025 reading of $259.0 million, up 14.04% over the prior year.
  • Raw Materials was $259.0 million for Q4 2025 at Axcelis Technologies, up from $250.5 million in the prior quarter.
  • Across five years, Raw Materials topped out at $259.0 million in Q4 2025 and bottomed at $100.6 million in Q1 2021.
  • Average Raw Materials over 5 years is $193.5 million, with a median of $217.2 million recorded in 2023.
  • The sharpest move saw Raw Materials soared 42.37% in 2023, then fell 4.88% in 2025.
  • Year by year, Raw Materials stood at $133.8 million in 2021, then surged by 40.01% to $187.3 million in 2022, then increased by 23.43% to $231.2 million in 2023, then fell by 1.76% to $227.1 million in 2024, then rose by 14.04% to $259.0 million in 2025.
  • Business Quant data shows Raw Materials for ACLS at $259.0 million in Q4 2025, $250.5 million in Q3 2025, and $243.5 million in Q2 2025.